Wallace joined Oxford Science Enterprises in March 2022. She first joined the life science team and has since transitioned to focus on established companies.
Wallace joined OSE from M-Ventures, the corporate venture capital arm of Merck KGaA, where she supported the life sciences investment team across scientific due diligence and portfolio management. Before this, Wallace worked at Accenture as a consultant, assisting the Business Strategy and Operation Strategy units, advising financial services clients.
Wallace holds a BSc in Genetics from the University of York and an MPhil in Bioscience Enterprise from the University of Cambridge.